ES2095739T4 - Estabilizacion de emulsiones de fluorocarbono. - Google Patents

Estabilizacion de emulsiones de fluorocarbono.

Info

Publication number
ES2095739T4
ES2095739T4 ES94901211T ES94901211T ES2095739T4 ES 2095739 T4 ES2095739 T4 ES 2095739T4 ES 94901211 T ES94901211 T ES 94901211T ES 94901211 T ES94901211 T ES 94901211T ES 2095739 T4 ES2095739 T4 ES 2095739T4
Authority
ES
Spain
Prior art keywords
fluorocarbon
mixture
phase
stabilization
emulsions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94901211T
Other languages
English (en)
Other versions
ES2095739T3 (es
Inventor
Jeffry Greg Weers
David Henry Klein
Cindy Shizuko Johnson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alliance Pharmaceutical Corp
Original Assignee
Alliance Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alliance Pharmaceutical Corp filed Critical Alliance Pharmaceutical Corp
Publication of ES2095739T3 publication Critical patent/ES2095739T3/es
Application granted granted Critical
Publication of ES2095739T4 publication Critical patent/ES2095739T4/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Surgery (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials Applied To Surfaces To Minimize Adherence Of Mist Or Water (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Colloid Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

EMULSIONES DE FLUOCARBUROS DE CONSERVACION ESTABLE QUE TIENE UNA FASE ACUOSA CONTINUA Y UNA FASE DE FLUOCARBUROS DISCONTINUA, EN DONDE LA FASE DE FLUOROCARBUROS CONTIENE UNA CANTIDAD PRINCIPAL DE UN PRIMER FLUOROCARBURO O MEZCLA DE FLUOCARBUROS Y UNA CANTIDAD MENOR DE UN SEGUNDO FLUOROCARBURO O MEZCLA DE FLUOROCARBUROS, EN DONDE EL SEGUNDO FLUOROCARBURO TIENE UN PESO MOLECULAR MAYOR QUE EL DEL PRIMER FLUOROCARBURO Y EL SEGUNDO FLUOROCARBURO INCLUYE UNA UNIDAD LIPOFILICA EN SU ESTRUCTURA, CON LO QUE EL SEGUNDO FLUOROCARBURO ACTUA PARA PROMOVER LA ESTABILIDAD DEL TAMAÑO DE LAS PARTICULAS DE LA EMULSION AL TIEMPO QUE PROPORCIONA UNOS TIEMPOS DE RETENCION EN LOS ORGANOS FAVORABLEMENTE CORTOS CUANDO SE ADMINISTRA A ANIMALES IN VIVO.
ES94901211T 1992-10-27 1993-10-27 Estabilizacion de emulsiones de fluorocarbono. Expired - Lifetime ES2095739T4 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/967,700 US5628930A (en) 1992-10-27 1992-10-27 Stabilization of fluorocarbon emulsions

Publications (2)

Publication Number Publication Date
ES2095739T3 ES2095739T3 (es) 1997-02-16
ES2095739T4 true ES2095739T4 (es) 1997-04-01

Family

ID=25513189

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94901211T Expired - Lifetime ES2095739T4 (es) 1992-10-27 1993-10-27 Estabilizacion de emulsiones de fluorocarbono.

Country Status (11)

Country Link
US (5) US5628930A (es)
EP (1) EP0666736B1 (es)
JP (2) JP3854630B2 (es)
AT (1) ATE146358T1 (es)
AU (1) AU678418B2 (es)
CA (1) CA2146757C (es)
DE (1) DE69306810T2 (es)
DK (1) DK0666736T3 (es)
ES (1) ES2095739T4 (es)
GR (1) GR3022641T3 (es)
WO (1) WO1994009625A2 (es)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2679150A1 (fr) * 1991-07-17 1993-01-22 Atta Preparations comprenant un fluorocarbure ou compose hautement fluore et un compose organique lipophile-fluorophile, et leurs utilisations.
US6875420B1 (en) 1991-09-17 2005-04-05 Amersham Health As Method of ultrasound imaging
MX9205298A (es) * 1991-09-17 1993-05-01 Steven Carl Quay Medios gaseosos de contraste de ultrasonido y metodo para seleccionar gases para usarse como medios de contraste de ultrasonido
US5628930A (en) * 1992-10-27 1997-05-13 Alliance Pharmaceutical Corp. Stabilization of fluorocarbon emulsions
IL108416A (en) 1993-01-25 1998-10-30 Sonus Pharma Inc Colloids with phase difference as contrast ultrasound agents
US5558855A (en) * 1993-01-25 1996-09-24 Sonus Pharmaceuticals Phase shift colloids as ultrasound contrast agents
US5726209A (en) * 1995-06-07 1998-03-10 Alliance Pharmaceutical Corp. Liquid fluorocarbon emulsion as a vascular nitric oxide reservoir
FR2737972B1 (fr) * 1995-08-24 1997-09-26 Oreal Emulsion ayant une texture aeree
US5814601A (en) * 1997-02-28 1998-09-29 The Regents Of The University Of California Methods and compositions for optimization of oxygen transport by cell-free systems
DE69831248T2 (de) * 1997-02-28 2006-04-13 The Regents Of The University Of California, Oakland Verfahren und zusammensetzungen zur optimierung des sauerstofftransportes in zellfreien systemen
DE10022541A1 (de) * 2000-02-24 2001-09-13 Hartmut Belis Verfahren zur Oberflächenbearbeitung von Stahlteilen und damit hergestellte Stahlteile
RU2206319C2 (ru) 2000-07-20 2003-06-20 Открытое акционерное общество Научно-производственная фирма "Перфторан" Эмульсия перфторорганических соединений для медицинских целей, способ ее приготовления и способы лечения и профилактики заболеваний с ее использованием
US20030031911A1 (en) * 2001-04-13 2003-02-13 Rosalyn Ritts Biocompatible membranes and fuel cells produced therewith
US20030113606A1 (en) * 2001-04-13 2003-06-19 Rosalyn Ritts Biocompatible membranes of block copolymers and fuel cells produced therewith
US20030087144A1 (en) * 2001-04-13 2003-05-08 Hoi-Cheong Steve Sun Enzymatic fuel cell with fixed dehydrogenase enzyme
US20030049511A1 (en) * 2001-04-13 2003-03-13 Rosalyn Ritts Stabilized biocompatible membranes of block copolymers and fuel cells produced therewith
US20050164915A1 (en) * 2002-04-01 2005-07-28 Sangart, Inc. Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
US20030153491A1 (en) * 2002-01-11 2003-08-14 Winslow Robert M. Methods and compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
US7619012B2 (en) * 2006-07-18 2009-11-17 The Regents Of The University Of California Method and apparatus for steam hydro-gasification in a fluidized bed reactor
US20080031809A1 (en) 2006-07-18 2008-02-07 Norbeck Joseph M Controlling the synthesis gas composition of a steam methane reformer
ES2305368T3 (es) * 2002-05-10 2008-11-01 THE PROCTER & GAMBLE COMPANY Tisu estampado en relieve que tiene fibras superficiales sueltas y metodo para su produccion.
JP3912206B2 (ja) * 2002-07-05 2007-05-09 株式会社日立製作所 筒内直接燃料噴射装置用燃料ポンプ
US7767232B2 (en) * 2002-09-19 2010-08-03 New York University Control of nitric oxide bioactivity by perfluorocarbons
DK1558226T3 (da) 2002-10-11 2012-05-07 Baxter Int Fremgangsmåde til cardiobeskyttelse og neurobeskyttelse ved intravenøs indgivelse af halogenerede, flygtige anæstetika
CN1997691B (zh) * 2003-09-23 2011-07-20 北卡罗来纳大学查珀尔希尔分校 光固化的全氟聚醚用作微流体器件中的新材料
CA2549524A1 (en) * 2004-01-02 2005-07-28 Wisconsin Alumni Research Foundation Encapsulation of chemical compounds in fluorous-core and fluorous-inner-shell micelles formed from semifluorinated-block or fluorinated-block copolymers
US8158728B2 (en) 2004-02-13 2012-04-17 The University Of North Carolina At Chapel Hill Methods and materials for fabricating microfluidic devices
CN101189271A (zh) * 2004-02-13 2008-05-28 北卡罗来纳大学查珀尔希尔分校 制造微流体设备的功能材料和新型方法
RU2259819C1 (ru) * 2004-03-01 2005-09-10 Кузнецова Ирина Николаевна Эмульсия перфторорганических соединений медицинского назначения и способ её получения
US7371714B2 (en) * 2005-06-23 2008-05-13 The United States Of America As Represented By The Secretary Of The Army Chemical agent decontamination composition comprising a perfluorinated alkyl bromide
US20070026024A1 (en) * 2005-07-27 2007-02-01 Drees Thomas C Compositions and methods for emulsifying a pefluorocarbon with an oxygen-carrying surfactant
US20090117207A1 (en) * 2005-11-29 2009-05-07 Zoltani Csaba K Methods and compositions for treatment of poison-caused pathology
AU2007225423A1 (en) * 2006-02-24 2007-09-20 Dow Global Technologies Llc Emulsion of a liquid fluorinated oil phase in a liquid water phase
AU2007249200B2 (en) * 2006-05-15 2013-12-19 Virginia Commonwealth University Methods and compositions for controlled and sustained production and delivery of peroxides
CN101448485B (zh) 2006-05-22 2013-01-09 联合制药公司 用于血液替代品和其他治疗用途的优化的氟碳乳剂
US9000048B2 (en) 2006-11-28 2015-04-07 Wisconsin Alumni Research Foundation Fluoropolymer-based emulsions for the intravenous delivery of fluorinated volatile anesthetics
US8900562B2 (en) * 2007-01-12 2014-12-02 Wisconsin Alumni Research Foundation Semi-fluorinated block copolymers for delivery of therapeutic agents
US20090202617A1 (en) * 2008-02-13 2009-08-13 Ward Kevin R Gas based wound and tissue therapeutics
AU2009271530B2 (en) * 2008-07-18 2016-01-07 Oxygen Biotherapeutics, Inc. Method of treating traumatic brain injury
US20100093873A1 (en) * 2008-10-02 2010-04-15 Goldfischer Sidney L Methods of improving therapy of perfluorocarbons (PFC)
WO2010077671A2 (en) 2008-12-08 2010-07-08 University Of Utah Research Foundation Stable perfluorocarbon emulsion for use as an artificial oxygen carrier
US20100144597A1 (en) * 2008-12-10 2010-06-10 Ward Kevin R Novel combinatorial approaches to enhancing oxygen transport to tissues
US20100267842A1 (en) * 2009-04-15 2010-10-21 Richard Kiral Emulsions of Perfluorocarbons
WO2012003457A1 (en) * 2010-07-01 2012-01-05 Mtm Research Llc Anti-fibroblastic fluorochemical emulsion therapies
US9700523B2 (en) 2011-10-13 2017-07-11 Nuvox Pharma Llc Buffered oxygen therapeutic
US8822549B2 (en) 2011-10-13 2014-09-02 Jennifer L. Johnson Buffered oxygen therapeutic
US11406722B2 (en) * 2017-03-16 2022-08-09 The Board Of Regents Of The University Of Texas System Nanodroplets with improved properties

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4289499A (en) * 1978-10-13 1981-09-15 Childrens Hospital Medical Center Selecting perfluorocarbon compounds for synthetic blood
FR2523956A1 (fr) * 1982-03-26 1983-09-30 Ugine Kuhlmann Bis-(perfluoroalkyl)-1,2-ethenes ramifies, leur preparation et leur utilisation comme transporteurs d'oxygene convertisseur electromecanique
GB8504916D0 (en) * 1985-02-26 1985-03-27 Isc Chemicals Ltd Emulsions of perfluorocarbons in aqueous media
US5080885A (en) * 1986-01-14 1992-01-14 Alliance Pharmaceutical Corp. Brominated perfluorocarbon emulsions for internal animal use for contrast enhancement and oxygen transport
US4927623A (en) * 1986-01-14 1990-05-22 Alliance Pharmaceutical Corp. Dissolution of gas in a fluorocarbon liquid
US4987154A (en) * 1986-01-14 1991-01-22 Alliance Pharmaceutical Corp. Biocompatible, stable and concentrated fluorocarbon emulsions for contrast enhancement and oxygen transport in internal animal use
US4865836A (en) * 1986-01-14 1989-09-12 Fluoromed Pharmaceutical, Inc. Brominated perfluorocarbon emulsions for internal animal use for contrast enhancement and oxygen transport
US4895876A (en) * 1987-03-20 1990-01-23 Air Products And Chemicals, Inc. Concentrated stable fluorochemical aqueous emulsions containing triglycerides
US4866096A (en) * 1987-03-20 1989-09-12 Air Products And Chemicals, Inc. Stable fluorochemical aqueous emulsions
US5171755A (en) * 1988-04-29 1992-12-15 Hemagen/Pfc Emulsions of highly fluorinated organic compounds
US4993415A (en) * 1988-08-19 1991-02-19 Alliance Pharmaceutical Corp. Magnetic resonance imaging with perfluorocarbon hydrides
DE4019062A1 (de) * 1989-08-30 1991-03-07 Kali Chemie Ag Stabilisierung von perfluorcarbonemulsionen und als emulsionsstabilisierende zusaetze verwendbare perfluorierte heterocyclische verbindungen
FR2679150A1 (fr) * 1991-07-17 1993-01-22 Atta Preparations comprenant un fluorocarbure ou compose hautement fluore et un compose organique lipophile-fluorophile, et leurs utilisations.
US5264220A (en) * 1991-11-12 1993-11-23 Long David M Jr Method of extending the vascular dwell-time of particulate therapeutic and particulate diagnostic agents
US5344393A (en) * 1992-02-28 1994-09-06 Alliance Pharmaceutical Corp. Use of synthetic oxygen carriers to facilitate oxygen delivery
DE4211958A1 (de) * 1992-04-01 1993-10-21 Pharmpur Gmbh Behandlungsmittel für die Augenheilkunde und seine Verwendung
US5628930A (en) * 1992-10-27 1997-05-13 Alliance Pharmaceutical Corp. Stabilization of fluorocarbon emulsions
FR2700696B1 (fr) * 1993-01-28 1995-04-07 Atta Dispersions, émulsions, microémulsions, gels et compositions à usage biomédical comprenant un composé organique fluoré iodé, utilisables notamment comme agent de contraste.
US5635538A (en) * 1993-03-16 1997-06-03 Alliance Pharmaceutical Corp. Fluorocarbon emulsions with reduced pulmonary gas-trapping properties
US5674913A (en) * 1994-05-13 1997-10-07 Synthetic Blood International, Inc. Method for assisting normal breathing in a mammal having a lung disorder
US5502094A (en) * 1994-05-20 1996-03-26 Minnesota Mining And Manufacturing Company Physiologically acceptable emulsions containing perfluorocarbon ether hydrides and methods for use
US5874481A (en) * 1995-06-07 1999-02-23 Alliance Pharmaceutical Corp. Fluorochemical solutions for the delivery of lipophilic pharmaceutical agents

Also Published As

Publication number Publication date
ATE146358T1 (de) 1997-01-15
GR3022641T3 (en) 1997-05-31
WO1994009625A2 (en) 1994-05-11
JPH08502753A (ja) 1996-03-26
US20020065326A1 (en) 2002-05-30
US20040068020A1 (en) 2004-04-08
JP2006160742A (ja) 2006-06-22
WO1994009625A3 (en) 1994-07-21
DK0666736T3 (da) 1996-12-18
DE69306810T2 (de) 1997-06-26
AU5587894A (en) 1994-05-24
EP0666736B1 (en) 1996-12-18
CA2146757C (en) 2004-09-21
EP0666736A1 (en) 1995-08-16
DE69306810D1 (de) 1997-01-30
US5628930A (en) 1997-05-13
US20050256211A9 (en) 2005-11-17
AU678418B2 (en) 1997-05-29
ES2095739T3 (es) 1997-02-16
US5914352A (en) 1999-06-22
CA2146757A1 (en) 1994-05-11
US6204296B1 (en) 2001-03-20
JP3854630B2 (ja) 2006-12-06

Similar Documents

Publication Publication Date Title
ES2095739T3 (es) Estabilizacion de emulsiones de fluorocarbono.
DE69004094T2 (de) Mehrphasige injizierbare emulsionen.
CA2259297A1 (en) Parenteral paclitaxel in a stable non-toxic formulation
ATE66366T1 (de) Kortikoidhaltige zubereitung zur topischen applikation.
ES2102157T3 (es) Emulsion agua en aceite para uso cosmetico o farmaceutico.
WO1996028131A3 (de) Kosmetische oder pharmazeutische mikroemulsionen
DE60000820T2 (de) Alpha-azacyclomethylchinolinderivate zur behandlung von harninkontinenz
KR840006280A (ko) α-시아노-3-페녹시-4-플루오로벤질 2'2-디메틸-3-(β'β-디클로로비닐)-시클로프로판 카복실레이트 함유 유인제의 제조방법
ATE269047T1 (de) Emulgatorfreie und bornitrid enthaltende feindisperse systeme vom typ öl-in-wasser und wasser-in-öl
IL151311A0 (en) Pharmaceutical compositions containing propofol
ES2147784T3 (es) Mejoras en o relacionadas con un agente de contraste.
KR910007509A (ko) 친유성 약제용 주사 조성물
DE69531736D1 (de) Oxytetracyclin enthaltendes arzneimittel mit verzögerter wirksoffabgabe
DK0437225T3 (da) Topiske præparater
DE50009291D1 (de) Fliessfähige zubereitungen vom emulsionstyp w/o mit erhöhtem wassergehalt mit einem gehalt an mittelpolaren lipiden
GB2362105A (en) Aciclovir compositions containing dimethicone
KR890011594A (ko) 4-아로일이미다졸-2-온의 제약 조성물
KR920016021A (ko) 동물의 발육 촉진 또는 개선 사료 및 방법
ES2043093T3 (es) Composicion para uso cosmetico o farmaceutico.
KR910009248A (ko) 칼씨토닌을 직장투여하기위한 무수 약제학적 제형 및 투약형태
KR890001556A (ko) 약제학적 조성물
TH21705A (th) สารผสมสำหรับใช้เฉพาะที่ซี่งประกอบด้วย n-แอซีทิล-l-ซิสเทซิสเทอีน
TH21705B (th) สารผสมสำหรับใช้เฉพาะที่ซี่งประกอบด้วย n-แอซีทิล-l-ซิสเทซิสเทอีน
TH55705B (th) สารช่วยสำหรับใช้ในวัคซีน

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 666736

Country of ref document: ES